Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder

NCT: NCT06874374 · ACTIVE_NOT_RECRUITING

NCT IDNCT06874374
StatusACTIVE_NOT_RECRUITING
Start Date2025-04-11
Completion2026-06-22

Brief Summary

The purpose of this research study is to study a closed-loop transcranial alternating current stimulation (tACS) device to evaluate feasibility of the product in a clinical trial and collect preliminary data on potential effects on symptoms of depression in people with major depressive disorder.

Frequently Asked Questions

What is Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder?

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder is a clinical trial registered under NCT06874374. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06874374?

The current status of NCT06874374 (Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder) is: ACTIVE_NOT_RECRUITING.

When did Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder start?

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder started on 2025-04-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑